Anxiety and Addiction: How Co-Occurring Anxiety Disorders Are Treated

Anxiety disorders and substance use disorder (SUD) are among the most common co-occurring conditions in adult behavioral health. People living with chronic anxiety often reach for alcohol, benzodiazepines, cannabis, or other substances to take the edge off, and over time the relationship becomes mutually reinforcing: the substance quiets anxiety in the short term and deepens it in the long term. This guide explains what anxiety disorders are in clinical terms, why they tangle so often with substance use, what integrated treatment looks like, and what recovery from both conditions involves.

This page is informational. If you are looking for treatment, see the levels of care section, or call (888) 464-2144 to speak with admissions at The Archangel Centers.

The link between anxiety and substance use is well-described in the clinical literature. Most adults with co-occurring conditions do not start using substances to get high; they use to manage symptoms. The pattern is sometimes called the self-medication cycle, and it follows a predictable arc.

In the early stage, a person discovers that alcohol, a benzodiazepine, cannabis, or another substance reliably reduces anxiety in the moment. The brain registers that the substance worked. Use becomes a coping tool, often outside of any conscious decision to make it one. Over weeks and months, tolerance builds, dose climbs, and the substance is needed more often and in larger amounts to produce the same relief.

Then the relationship inverts. Long-term alcohol use disrupts GABA and glutamate balance and produces rebound anxiety between drinks, often felt as morning shakes, racing heart, or a low-grade sense of dread. Long-term benzodiazepine use produces inter-dose withdrawal that mimics and amplifies the original anxiety. Stimulants (cocaine, methamphetamine, high-dose prescription stimulants) directly trigger anxiety, panic, and insomnia. Cannabis, in heavy or daily use, is associated with worsened anxiety and panic in many users. The substance that started as a treatment becomes a driver.

By the time a person seeks help, it is often impossible to tell which came first, the anxiety or the substance use, without a careful clinical history. The honest answer in most cases is that both conditions now feed each other and both need to be treated.

Anxiety disorders have one of the strongest evidence bases of any condition in mental health. Several specific modalities, used alone or in combination, are well-documented to reduce anxiety symptoms and to support recovery from co-occurring substance use.

• **Cognitive behavioral therapy (CBT)** is the first-line treatment for most anxiety disorders. CBT for anxiety has two core moves: cognitive restructuring (identifying and challenging catastrophic predictions, all-or-nothing thinking, and probability distortions) and exposure (graded, repeated contact with feared situations until the anxiety response habituates). For panic, this includes interoceptive exposure to feared body sensations. For social anxiety, behavioral experiments that test feared social outcomes. For GAD, worry exposure and uncertainty tolerance work.
• **Dialectical behavior therapy (DBT) skills** — particularly distress tolerance, emotion regulation, and mindfulness — give clients tools to ride out acute anxiety without reaching for a substance. Distress tolerance skills are especially useful in the first weeks of abstinence, when panic and rebound anxiety are most intense.
• **Motivational interviewing (MI)** is a collaborative conversational style that helps clients resolve the very real ambivalence about giving up a substance that was, for a while, working as anxiety relief. MI does not push; it strengthens the client's own reasons for change.
• Trauma-informed care is integrated into individual therapy for clients whose anxiety is linked to unresolved traumatic experience. Programming is trauma-informed across the board, and trauma-focused work is delivered in individual sessions when the clinical presentation supports it.

Recovery from co-occurring anxiety and SUD is not a single moment of resolution. It is a sequence, and the sequence matters. The first weeks are usually about stabilization: getting the substance use interrupted safely, restoring sleep, restoring nutrition, building basic distress tolerance skills, and starting medication where indicated. Anxiety often gets worse before it gets better in this phase, which is expected and prepared for, not a sign that treatment is failing.

Once stabilization is in place, the deeper anxiety work begins. Exposure work proceeds on a graded plan. Cognitive restructuring becomes possible because the client has the regulatory bandwidth to do it. Trauma work, where indicated, is taken up in individual therapy. Family work, if the client consents, addresses the interpersonal context that has often supported both the anxiety and the substance use.

Realistic timelines vary by person. Substance use behavior often stabilizes within weeks. Anxiety symptoms typically improve over months, with CBT and SSRIs producing measurable change in the eight-to-twelve-week range, and continued improvement over a year. Recovery is not the absence of anxiety; it is the presence of a sustainable structure that lets the person live well even when anxiety is present. What predicts a sustainable outcome:

• Both conditions treated together, in one plan, by one team, from admission
• Treatment matched to symptom severity, with step-down structured rather than abrupt
• Medication decisions made collaboratively, with SSRIs or SNRIs considered first-line for most clients
• Benzodiazepines handled with caution in any client with a SUD history
• Continued clinical contact through OP and alumni community, not a single program episode
• Time — brain healing and habit change take months, and both conditions reward patience